ZA200608015B - Heteroarylaminopyrazole derivatives useful for the treatment of diabetes - Google Patents

Heteroarylaminopyrazole derivatives useful for the treatment of diabetes

Info

Publication number
ZA200608015B
ZA200608015B ZA200608015A ZA200608015A ZA200608015B ZA 200608015 B ZA200608015 B ZA 200608015B ZA 200608015 A ZA200608015 A ZA 200608015A ZA 200608015 A ZA200608015 A ZA 200608015A ZA 200608015 B ZA200608015 B ZA 200608015B
Authority
ZA
South Africa
Prior art keywords
heteroarylaminopyrazole
diabetes
treatment
derivatives useful
derivatives
Prior art date
Application number
ZA200608015A
Other languages
English (en)
Inventor
Rudolph Joachim
Wickens Philip
Chuang Chih-Yuan
Chen Libing
Magnuson Steven
Olague Alan
Qi Ning
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of ZA200608015B publication Critical patent/ZA200608015B/xx

Links

ZA200608015A 2004-02-27 2006-09-27 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes ZA200608015B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54833104P 2004-02-27 2004-02-27

Publications (1)

Publication Number Publication Date
ZA200608015B true ZA200608015B (en) 2008-12-31

Family

ID=38045478

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200608015A ZA200608015B (en) 2004-02-27 2006-09-27 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes

Country Status (3)

Country Link
CN (1) CN1946715A (es)
GT (1) GT200500033A (es)
ZA (1) ZA200608015B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106866536A (zh) * 2017-04-12 2017-06-20 中国农业大学 一种制备4‑卤代‑5‑氨基吡唑的方法

Also Published As

Publication number Publication date
GT200500033A (es) 2005-09-30
CN1946715A (zh) 2007-04-11

Similar Documents

Publication Publication Date Title
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AP2007004157A0 (en) N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
HK1127489A1 (en) Pyridiazinone derivatives for the treatment of tumours
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
EP1744751A4 (en) TREATMENT OF SYNUCLEINOPATHIES
EP1804794A4 (en) SPIROPIPERIDINE COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
PT1802579E (pt) Derivados da 3-arilaminopiridina
HK1116077A1 (en) Roflumilast for the treatment of diabetes mellitus
ZA200704154B (en) Substituted benzoquinolizines as DPP-IV inhibitors for the treatment of diabetes
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
EP1809265A4 (en) METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES
ZA200706113B (en) Method for the treatment of copper-bearing materials
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
EP1732549A4 (en) METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
EP1753446A4 (en) ALPHA-1 GLYCOPROTEIN ACID FOR THE TREATMENT OF DIABETES
EP1889618A4 (en) COMBINED MEDICINE FOR THE TREATMENT OF DIABETES
PL1959957T3 (pl) Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
IL179670A0 (en) Heterocyclic compounds and processes for the preparation thereof
HK1097831A1 (en) Benzopyran compounds useful for the treatment of arrhytmia
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
IL189928A0 (en) Thiophene derivatives for the treatment of diabetes
EP1718294A4 (en) METHODS OF TREATING COMPLICATIONS OF DIABETES
GB0400802D0 (en) Compounds for the treatment of disease
ZA200608015B (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes